J 2021

Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring

CABALLERO-CASERO, Noelia, Lidia BELOVA, Philippe VERVLIET, Jean-Philippe ANTIGNAC, Argelia CASTANO et. al.

Základní údaje

Originální název

Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring

Autoři

CABALLERO-CASERO, Noelia (56 Belgie), Lidia BELOVA (56 Belgie), Philippe VERVLIET (56 Belgie), Jean-Philippe ANTIGNAC (250 Francie), Argelia CASTANO (724 Španělsko), Laurent DEBRAUWER (250 Francie), Marta Esteban LOPEZ (724 Španělsko), Carolin HUBER (276 Německo), Jana KLÁNOVÁ (203 Česká republika, garant, domácí), Martin KRAUSS (276 Německo), Arjen LOMMEN (528 Nizozemské království), Hans G. J. MOL (528 Nizozemské království), Herbert OBERACHER (40 Rakousko), Olga PARDO (724 Španělsko), Elliott James PRICE (826 Velká Británie a Severní Irsko, domácí), Vera REINSTADLER (40 Rakousko), Chiara Maria VITALE (380 Itálie, domácí), Alexander L. N VAN NUIJS (56 Belgie) a Adrian COVACI (56 Belgie)

Vydání

TrAC Trends in Analytical Chemistry, Oxford, Elsevier, 2021, 0165-9936

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10406 Analytical chemistry

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 14.908

Kód RIV

RIV/00216224:14310/21:00122041

Organizační jednotka

Přírodovědecká fakulta

UT WoS

000637644000003

Klíčová slova anglicky

Quality control-quality assurance measures; Framework for analytical performance; Emerging compounds; Human matrices; Suspect and non-target screening; HBM4EU

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 4. 8. 2021 22:29, Mgr. Michaela Hylsová, Ph.D.

Anotace

V originále

Although the exposure assessment of chemicals of emerging concern (CECs) has taken a decisive step forward through advances in (bio)informatics, statistics, and the development of highly sophisticated analytical instruments, the lack of standardisation and harmonisation of analytical workflows and method performance assessment for suspect and non-target screening hampers the interpretation of results, their comparability and thus, its transmission to policymakers. To date, unlike in other research fields such as forensics or food analysis, there is a lack of guidelines for non-target analysis in human risk assessment and quality assurance and quality control (QA/QC) protocols. Moreover, the majority of efforts have been focused on the development and implementation of QA/QC actions for data acquisition, data analysis and mining, largely neglecting the sample preparation necessary for determination of CECs by suspect and non-target screening methods. In this article, we propose a set of QA/QC measures that covers sampling, sample preparation and data acquisition, as an aspect of work conducted within the European Biomonitoring for Europe initiative (HBM4EU). These measures include the use of standardised terminology and the implementation of dedicated QA/QC actions in each stage of the analytical process. Moreover, a framework for the analytical performance assessment has been developed for the first time for the identification of CECs in human samples by suspect and non-target approaches. Adoption of the actions proposed here for the identifi-cation of CECs in human matrices can significantly improve the comparability of reported results and contribute to the (challenging) Exposome research field.

Návaznosti

EF16_027/0008360, projekt VaV
Název: Postdoc@MUNI
733032, interní kód MU
Název: European Human Biomonitoring Initiative (Akronym: HBM4EU)
Investor: Evropská unie, European Human Biomonitoring Initiative, Health, demographic change and wellbeing (Societal Challenges)